Glyco Bio Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.60 M
as on 12-12-2024
- Revenue 41.84%
(FY 2022)
- Profit 159.16%
(FY 2022)
- Ebitda 32.74%
(FY 2022)
- Net Worth 123.61%
(FY 2022)
- Total Assets 20.40%
(FY 2022)
About Glyco Bio Pharma
The Company is engaged in the Events And Entertainment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.60 M.
Sekhar Mandava and Sujitha Mandava serve as directors at the Company.
- CIN/LLPIN
U74999TG2017PTC117995
- Company No.
117995
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Glyco Bio Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sekhar Mandava  | Director | 28-Jun-2017 | Current |
| Sujitha Mandava | Director | 28-Jun-2017 | Current |
Financial Performance of Glyco Bio Pharma.
Glyco Bio Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 41.84% increase. The company also saw a substantial improvement in profitability, with a 159.16% increase in profit. The company's net worth Soared by an impressive increase of 123.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glyco Bio Pharma?
In 2018, Glyco Bio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genetheraptics Pharma Private LimitedActive 7 years 1 monthSekhar Mandava and Sujitha Mandava are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 22 Mar 2022 | ₹3.60 M | Open |
How Many Employees Work at Glyco Bio Pharma?
Unlock and access historical data on people associated with Glyco Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glyco Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glyco Bio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
